May 25, 2017
2 min read
Save

Angle surgery effective long-term in children with glaucoma

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers found a favorable visual acuity outcome over a 21-year period in children with primary congenital glaucoma who underwent angle surgery.

Perspective from Carl H. Jacobsen, OD, FAAO

The retrospective study included patients who underwent trabeculotomy, trabeculectomy or combined trabeculotomy-trabeculectomy (CTT) for primary congenital glaucoma.

Researchers compared visual acuity, surgeries and underlying cause of visual impairment in 53 eyes. Median age at diagnosis was 2 months, and sex distribution between male and female patients was equal.

Primary surgical intervention was CTT for 26 eyes, trabeculotomy for 19 eyes and trabeculectomy for eight eyes. Nine eyes required a second surgery.

The mean logMAR visual acuity was 0.61.

A good visual acuity was attained in 27 eyes (51%), moderate in 16 eyes (30%) and poor in 10 eyes (19%). The mean spherical equivalent of refraction was -4.47. The predominant refraction errors were myopia (74%) and astigmatism greater than 2 D (40%).

The mean IOP at presentation was 26.23 mm Hg and 14.96 mm Hg at final follow-up, representing a 42.9% reduction, according to the study. There was no statistically significant correlation between visual acuity categories, with or without medication.

Also, the researchers reported no correlation between mean spherical equivalent of refraction and medication use.

None of the studied risk factors – age at surgery, sex, laterality, type of initial glaucoma surgery, number of surgeries or type of control – were statistically associated with moderate to poor visual outcome, according to researchers.

The researchers also highlighted the role of topical antiglaucoma medication in improving the success rate of surgery remarkably without risking visual outcome. – by Abigail Sutton

Disclosures: The researchers report no relevant financial disclosures.